Poor management

Discussion in 'Neogenomics' started by anonymous, Apr 23, 2016 at 7:49 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Just when we thought and hoped the grass would be greener. How can 8,000 tests come out and never properly launched. We don't even know what last weeks test does and we have a new one this week. We're spending money and under utilizing what we're investing in.
    What does AC do?
    What does MM do?
     

  2. anonymous

    anonymous Guest


    We know what you do all day. Instead of building a company and contributing you post on an anonymous board and call others out. Shame on you!
     
  3. anonymous

    anonymous Guest

    Different person writing. But I feel like if anyone is disgruntled they should voice their opinions properly to HR or to your manager. Since this an open forum everyone has their own right.
    Calling people out in our organization is easy. We have high levels that are way over paid, unworthy people in executive positions, and C suite sitters hitting on reps.. Sounds like a well rounded corporation to me.
    The end
     
  4. anonymous

    anonymous Guest


    They're valuable members of the Neo family. If you're not happy here you should leave, we've got an important mission to accomplish and with posts like this, I can tell you're not aligned with what we're doing...you should probably quit.
     
  5. anonymous

    anonymous Guest

    mission:
    Appease the shareholders and keep hiding in the pack and wonder how long this can keep going on
     
  6. anonymous

    anonymous Guest

    Moving everything to Texas and Florida in 2 years, guarateed
     
  7. anonymous

    anonymous Guest

     
  8. anonymous

    anonymous Guest


    Do Any of these tests sell? Do Pathologists and Oncologists Accept them and trust in them? Are they actually actionable. Please help with legitimate answers. I am trying to decide on whether not to allow them to be presented at our next Office Technology meeting. My Oncologists don't like to run random tests nor be the first with new technology.